Although most patients in the real-world setting would not have met the clinical trial eligibility criteria, the efficacy and safety outcomes with idecabtagene vicleucel were similar for both sets of patients with multiple myeloma.
Patients in the CARTITUDE-4 trial experienced a high response rate to the treatment as early as their first relapse.
The establishment of a multidisciplinary committee can help identify opportunities to best face the ongoing cancer drug shortage.
Tools to educate oncology nurses and patients on the use of Mepitel film to prevent radiation dermatitis has improved the workflow around its introduction to…
Older patients with cancer demonstrated a moderate to high symptom burden, leading to the need for routine symptom assessments and tailored management interventions.
Over 500 attendees at this in-person event celebrated the incredible efforts made by oncology nurses when caring for patients with cancer.
Oncology nurses can educate their patients on the latest developments in CAR T-cell therapy for the treatment of glioblastoma.
An expert discussed a screening tool that she and her colleagues used to connect patients with cancer to palliative care services in a more effective…
Lutetium Lu 177 dotatate was approved by the FDA for children aged 12 years and older with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
Patients with BRCA wild-type triple-negative breast cancer treated with olaparib on a gap schedule with chemotherapy did not experience improved responses compared with chemotherapy alone…
Nogapendekin alfa inbakicept-pmln has been approved for use with BCG for the treatment of BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or…
